Skip to main content

Glyphosate Lawsuits Postponed For Settlement Talks

Glyphosate Lawsuits Postponed For Settlement Talks

Glyphosate Lawsuits Postponed For Settlement Talks

Introduction

Glyphosate-based weed killer Roundup lawsuits are being postponed to allow more time for talks on a settlement following an agreement between Bayer and plaintiffs in its next two U.S. lawsuits over allegations that it causes cancer.

According to the agreement, the cases scheduled for January 15 in California Superior Court for Lake County are delayed by six months. A second case to be held in California Superior Court of Alameda on January 21 would also be postponed for which the date is yet to be confirmed. Bayer stated that the delay would give additional time to them as well as to the representatives of the plaintiffs to productively involve in the mediation process.

Early next year, Bayer will also appeal to reverse the first three U.S. court rulings, which involved tens of millions of dollars to the plaintiffs. The trials which were initially scheduled for this year have already been postponed.

More than 18,000 lawsuits are filed against Roundup, which is consolidated under federal multidistrict litigation (MDL No. 2741; In Re: Roundup Products Liability Litigation) in the Northern District of California, presided by U.S. District Judge Vince Chhabria.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.